Drug makers to add drug reaction Acute Generalized Exanthematous Pustulosis in package insert of Cloxacillin: CDSCO Panel Susmita Roy21 Jan 2022 5:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Azithromycin drugmakers to add adverse reaction AGEP in the package insert: CDSCO Panel Medical Dialogues Team21 Jan 2022 2:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Covishield, Covaxin get regular market approval MD Bureau20 Jan 2022 4:39 PM ISTNew Delhi: India's two main vaccines, Bharat Biotech's Covaxin and Serum Institute of India's Covishield, on Wednesday got the nod for regular market...
Drug-makers to add Fixed Drug Eruption (FDE) in the package insert of Doxycycline : CDSCO Panel Medical Dialogues Team19 Jan 2022 5:21 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
CSDCO calls meeting of makers of 19 older FDCs to examine their rationality Dr. Divya Colin18 Jan 2022 4:45 PM ISTNew Delhi: With an aim to understand the rationality of certain older Fixed Dose Combination (FDC) molecules in the market, The Central Drug Standard...
CoSara Diagnostics gets CDSCO clearance for High-Risk HPV Multiplex Test Ruchika Sharma17 Jan 2022 4:17 PM ISTSalt Lake City: Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
Drug makers to add Itraconazole linked Photosensitivity in package insert: CDSCO panel Medical Dialogues Team16 Jan 2022 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Drug makers to include DPP4 inhibitors induced Arthralgia in package insert, says CDSCO panel Medical Dialogues Team15 Jan 2022 5:35 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Novartis gets CDSCO panel nod to study Alpelisib for early (prophylactic) and sustained improvement of hyperglycemia Medical Dialogues Team9 Jan 2022 8:45 PM ISTNew Delhi: Pharmaceutical major Novartis has got a conditional nod from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Ligelizumab in treatment of chronic inducible urticaria Medical Dialogues Team7 Jan 2022 2:21 PM ISTNew Delhi: Pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Dr Reddys to launch anti-COVID drug Molnupiravir under brand name Molflu at Rs 35 per capsule Medical Dialogues Bureau5 Jan 2022 3:53 PM IST"Molflu (Molnupiravir) is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high...
Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 11:45 PM ISTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19...
